Tipharco Pharmaceutical Joint Stock Company (HNX Code: DTG) has just announced the closing of the right to pay 2022 cash dividends at a rate of 5%. Accordingly, each shareholder owning 1 share will receive a dividend of 500 VND.
Currently, there are 6.3 million DTG shares in circulation on the market, so the company is expected to spend 3.12 billion VND for this cash dividend payment.
Tipharco Pharmaceuticals (DTG) pays cash dividend at a rate of 5% (Photo TL)
In addition, DTG also plans to issue additional shares at a rate of 15%. Accordingly, each shareholder owning 100 shares will receive 15 new shares. The expected issuance volume will be 947,389 shares. The issuance fund will be drawn from undistributed after-tax profits as of December 31, 2022.
Regarding business performance, in the second quarter of 2023, Tipharco Pharmaceuticals recorded net revenue of VND 78.3 billion, gross profit from sales of VND 19 billion, equivalent to a gross profit margin of 24.3%. Profit after corporate income tax reached VND 3.9 billion.
By the end of the second quarter, DTG's total assets reached VND298.3 billion. Of which, liabilities accounted for VND150.5 billion, equivalent to 50.5% of total capital. Owner's equity reached VND147.8 billion, equivalent to 49.5% of capital.
At the trading session on August 15, 2023, DTG shares were being traded at VND 30,300/share, down about 21.9% compared to the peak of VND 38,800/share reached on July 10, 2023 when the shares were officially traded on the HNX stock exchange after transferring from UPCoM.
Source
Comment (0)